Pegylated Interferon and Ribavirin Treatment of Chronic Hepatitis C Coinfection in a Patient with Human Immunodeficiency Virus Infection

被引：0
|
作者：
Kaptan, Figen [1 ]
Turker, Nesrin [1 ]
Ormen, Bahar [1 ]
El, Sibel [1 ]
Hekimoglu, Can Huseyin [1 ]
Vardar, Ilknur [1 ]
Ural, Serap [1 ]
Sener, Asli Gamze [2 ]
Coskun, Nejat Ali [1 ]
机构：
[1] Izmir Ataturk Egitim & Arastirma Hastanesi, Infeksiyon Hastaliklari & Klin Mikrobiyol Klin, Izmir, Turkey
[2] Izmir Ataturk Egitim & Arastirma Hastanesi, Tibbi Mikrobiyol Lab, Izmir, Turkey
来源：
KLIMIK JOURNAL | 2011年 / 24卷 / 02期
关键词：
HIV; HCV antibodies; coinfection; pegylated interferon alpha 2a; ribavirin;
D O I：
10.5152/kd.2011.30
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Human immunodeficiency virus (HIV) and hepatitis C virus (HCV)coinfection is seen frequently due to similar routes of transmission. In coinfected patients, progression of chronic hepatitis C (CHC) infection is accelerated. In this study, a 44-year old male patient with HIV/HCV (genotype 1b) coinfection is evaluated. For the treatment of CHC, pegylated interferon alpha 2a 180 mg per week and ribavirin 1000 mg/day were used for 48 weeks and sustained virologic response was achieved. During the course of CHC treatment no adverse effect was seen.
引用
收藏
页码：122 / 125
页数：4
相关论文
共 50 条
  • [1] Pegylated interferon and ribavirin treatment for hepatitis C virus infection
    Palumbo, Emilio
    [J]. THERAPEUTIC ADVANCES IN CHRONIC DISEASE, 2011, 2 (01) : 39 - 45
  • [2] Treatment of chronic hepatitis C in human immunodeficiency virus/hepatitis C virus-coinfected patients in the era of pegylated interferon and ribavirin
    Bräu, N
    [J]. SEMINARS IN LIVER DISEASE, 2005, 25 (01) : 33 - 51
  • [3] Treatment response of chronic hepatitis C virus infection with pegylated-interferon and ribavirin
    Humphris, J. L.
    Ngu, M. C.
    Lee, A. U.
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2006, 21 : A331 - A331
  • [4] Pegylated interferon with ribavirin therapy for chronic infection with the hepatitis C virus
    Foster, GR
    [J]. EXPERT OPINION ON PHARMACOTHERAPY, 2003, 4 (05) : 685 - 691
  • [5] Treatment with pegylated interferon and ribavirin in patients co-infected by human immunodeficiency virus and hepatitis C virus
    Sanchez, F. Marcos
    Castano, M. I. Albo
    Blanco, S. Casallo
    [J]. REVISTA CLINICA ESPANOLA, 2007, 207 (03): : 150 - 151
  • [6] Hepatitis C virus/human immunodeficiency virus coinfection in hemophiliacs: high rates of sustained virologic response to pegylated interferon and ribavirin therapy
    Mancuso, M. E.
    Rumi, M. G.
    Aghemo, A.
    Santagostino, E.
    Puoti, M.
    Coppola, A.
    Colombo, M.
    Mannucci, P. M.
    [J]. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2009, 7 (12) : 1997 - 2005
  • [7] Pegylated Interferon and Ribavirin for the Treatment of Chronic Hepatitis C
    Kemp, William
    Roberts, Stuart
    [J]. CLINICAL MEDICINE INSIGHTS-THERAPEUTICS, 2011, 3 : 137 - 150
  • [8] Treatment with pegylated interferon and ribavirin in patients co-infected by human immunodeficiency virus and hepatitis C virus - Response
    Cuerda, V. J. Moreno
    Conejo, M. Morales
    Rubio, R.
    [J]. REVISTA CLINICA ESPANOLA, 2007, 207 (03): : 151 - 151
  • [9] Chronic hepatitis C virus genotype 6 infection: Response to pegylated interferon and ribavirin
    Fung, James
    Lai, Ching-Lung
    Hung, Ivan
    Young, John
    Cheng, Charles
    Wong, Danny
    Yuen, Man-Fung
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2008, 198 (06): : 808 - 812
  • [10] Pegylated interferon and ribavirin therapy for chronic hepatitis C virus genotype 4 infection
    Legrand-Abravanel, F
    Nicot, F
    Boulestin, A
    Sandres-Sauné, K
    Vinel, JP
    Alric, L
    Izopet, J
    [J]. JOURNAL OF MEDICAL VIROLOGY, 2005, 77 (01) : 66 - 69
12345